| Product NDC: | 0187-0007 |
| Proprietary Name: | Virazole |
| Non Proprietary Name: | Ribavirin |
| Active Ingredient(s): | 6 g/1 & nbsp; Ribavirin |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0187-0007 |
| Labeler Name: | Valeant Pharmaceuticals North America LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018859 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19860101 |
| Package NDC: | 0187-0007-14 |
| Package Description: | 4 VIAL, GLASS in 1 CARTON (0187-0007-14) > 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS |
| NDC Code | 0187-0007-14 |
| Proprietary Name | Virazole |
| Package Description | 4 VIAL, GLASS in 1 CARTON (0187-0007-14) > 1 POWDER, FOR SOLUTION in 1 VIAL, GLASS |
| Product NDC | 0187-0007 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ribavirin |
| Dosage Form Name | POWDER, FOR SOLUTION |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 19860101 |
| Marketing Category Name | NDA |
| Labeler Name | Valeant Pharmaceuticals North America LLC |
| Substance Name | RIBAVIRIN |
| Strength Number | 6 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |